Artificial Intelligence Self Harm Application
AISHA
Exploratory Randomised Controlled Trial of an Artificial Intelligence Self Harm Application
1 other identifier
interventional
312
1 country
2
Brief Summary
This is a mixed-methods study. The quantitative component will comprise of a multicentre rater-blind, randomized controlled trial to evaluate the feasibility and acceptability of AISHA in addition to treatment as usual (TAU) compared to TAU alone in Pakistan. In-depth interviews and focus groups with other stakeholders will take place to consider the wider implementation of AISHA in mental health services in Pakistan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedMarch 5, 2024
March 1, 2024
1.1 years
August 25, 2023
March 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beck Scale for Suicide Ideation
This is a self-report measure of current suicidal ideation. Higher scores (≥6) on the scale indicate greater risk. When measured against other instruments of suicidal ideation, the convergent validity of the BSI has been demonstrated, r= 0. We have used the Urdu translated version of this instrument in prior work from Pakistan and found the Cronbach's alpha to be 0.89 (M. O. Husain et al., 2019). Higher scores indicate greater severity of suicidal ideation
Change in scores from baseline to 3-month follow up (end of intervention)
Secondary Outcomes (8)
Beck Hopelessness Scale
Change in scores from baseline to 3-month follow up (end of intervention)
Beck Depression Inventory
Change in scores from baseline to 3-month follow up (end of intervention)
Coping resource inventory
Change in scores from baseline to 3-month follow up (end of intervention)
The Resilience Scale
Change in scores from baseline to 3-month follow up (end of intervention)
The Problem Solving Inventory
Change in scores from baseline to 3-month follow up (end of intervention)
- +3 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALStandard Routine Care
NO INTERVENTIONStandard care for self-ham in Pakistan does not usually involve psychiatric or psychotherapy follow-up. Clinical teams in psychiatric departments or family medicine practices provide standard routine care according to their clinical judgment and available resources. We will obtain details of any treatment received by each participant
Interventions
YCMAP is a "Youth culturally adapted manual assisted psychological intervention" based on CBT principles. The therapy focuses on current problems that contributed to the self-harm episode. Therapists and adolescent clients choose from a list of techniques those which are most relevant to the client's problems. Therapy is therefore adapted to fit with the client's problems and primarily utilises problem solving, CBT, and dialectical therapy strategies to bring about change.
Eligibility Criteria
You may qualify if:
- All patients presented to the participating family physicians, community health centres, emergency departments or admitted to a general hospital after an episode of self-harm at participating sites.
- Age 16 to 25 years
- Participants must be familiar with functioning of handheld mobile devices (mobile phones, tablets).
- Able to read Urdu or English language.
- Individuals able to provide written informed consent.
- Have an android mobile phone/device
You may not qualify if:
- Participants with ICD-I0 mental disorder; due to a general medical condition or substance misuse, dementia, delirium, alcohol or drug dependence, schizophrenia, bipolar disorder, learning disability which prevents participation.
- Participants needing inpatient psychiatric treatment as determined by their clinical teams
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Benazir Bhutto Hospital
Rawalpindi, Punjab Province, 203393, Pakistan
Civil Hospital
Karachi, Sindh, 203393, Pakistan
Related Publications (2)
Husain N, Kiran T, Chaudhry IB, Williams C, Emsley R, Arshad U, Ansari MA, Bassett P, Bee P, Bhatia MR, Chew-Graham C, Husain MO, Irfan M, Khaliq A, Minhas FA, Naeem F, Naqvi H, Nizami AT, Noureen A, Panagioti M, Rasool G, Saeed S, Bukhari SQ, Tofique S, Zadeh ZF, Zafar SN, Chaudhry N. A culturally adapted manual-assisted problem-solving intervention (CMAP) for adults with a history of self-harm: a multi-centre randomised controlled trial. BMC Med. 2023 Jul 31;21(1):282. doi: 10.1186/s12916-023-02983-8.
PMID: 37525207BACKGROUNDHusain N, Tofique S, Chaudhry IB, Kiran T, Taylor P, Williams C, Memon R, Aggarwal S, Alvi MH, Ananiadou S, Ansari MA, Aseem S, Beck A, Alam S, Colucci E, Davidson K, Edwards S, Emsley R, Green J, Gumber A, Hawton K, Jafri F, Khaliq A, Mason T, Mcreath A, Minhas A, Naeem F, Naqvi HA, Noureen A, Panagioti M, Patel A, Poppleton A, Shiri T, Simic M, Sultan S, Nizami AT, Zadeh Z, Zafar SN, Chaudhry N. Youth Culturally adapted Manual Assisted Problem Solving Training (YCMAP) in Pakistani adolescent with a history of self-harm: protocol for multicentre clinical and cost-effectiveness randomised controlled trial. BMJ Open. 2022 May 13;12(5):e056301. doi: 10.1136/bmjopen-2021-056301.
PMID: 35568489BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2023
First Posted
August 31, 2023
Study Start
June 1, 2024
Primary Completion
June 30, 2025
Study Completion
December 30, 2025
Last Updated
March 5, 2024
Record last verified: 2024-03